top of page

BackTable / Tumor Board / Contributor

Dr. Siddharth Padia on the BackTable Tumor Board Podcast

Dr. Siddharth Padia

Interventional Radiologist

Dr. Sid Padia is an interventional radiologist at UCLA in Los Angeles, California.

Listen to Dr. Siddharth Padia on the BackTable Podcast

The BackTable Podcast is a knowledge resource by physicians for physicians. Learn from the experiences and expertise of Dr. Siddharth Padia and get practical advice on how to build your practice by listening to the BackTable Podcast.

Ep 9 Principles to Practice: An HCC Tumor Board with Dr. Gabe Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton and Dr. Sid Padia
00:00 / 01:04

Stay Up To Date

Follow:

Subscribe:

Sign Up:

About Dr. Siddharth Padia

Dr. Siddharth Padia, MD is a specialist in vascular and interventional radiology at UCLA Medical Center. His areas of clinical expertise and research interests include liver cancer, interventional oncology, vascular disease and portal hypertension.

Dr. Padia earned his medical degree from Johns Hopkins University School of Medicine. After completing his transitional internship at The University of Hawaii in Honolulu, Dr. Padia began his residency in diagnostic radiology at the Cleveland Clinic in Ohio and graduated as Chief Resident. After spending many years practicing interventional radiology at the University of Washington, Dr. Padia joined the faculty at UCLA.

Dr. Padia specializes in a novel way to treat liver cancer by infusing highly radioactive particles (Yttrium-90) into the liver, and has treated over 800 patients with this therapy. He recently refined the technique by focusing higher doses to small amounts of tissue. These resulted in a success rate in excess of 90% of patients with liver cancer, and potentially surpasses other forms of treatment for patients with liver cancer. Due to his expertise in this field, he is the primary author of the national treatment guidelines for Yttrium 90 radioembolization, and is a director of the national annual course to educate physicians on this therapy.

Learn more by visiting Dr. Siddharth Padia's practice:

Podcasts Featuring Dr. Siddharth Padia

MSK

MSK Episode #75

Who is the optimal candidate for GAE, which technical approach is best, and how do you set your patients up for success? Tune into this week’s episode of BackTable to hear from interventional radiologists Dr. Osman Ahmed (University of Chicago Medicine) and Dr. Siddharth Padia (UCLA Health) as they discuss everything from patient selection to follow-up care, covering pre-procedure imaging, access, embolics, technical challenges, clinical data, and the future of genicular artery embolization.

VI

VI Episode #535

Who is the optimal candidate for GAE, which technical approach is best, and how do you set your patients up for success? Tune into this week’s episode of BackTable to hear from interventional radiologists Dr. Osman Ahmed (University of Chicago Medicine) and Dr. Siddharth Padia (UCLA Health) as they discuss everything from patient selection to follow-up care, covering pre-procedure imaging, access, embolics, technical challenges, clinical data, and the future of genicular artery embolization.

VI

VI Episode #525

Do you ever wish you could be a fly on the wall at a tumor board meeting? In this episode of BackTable, we’re excited to give you an insider’s view of the real case discussions that take place during hepatocellular carcinoma (HCC) tumor boards. Host Dr. Zach Berman sits down with a multidisciplinary team, including Drs. Adam Burgoyne (medical oncologist), Heather Patton (hepatologist), Siddharth Padia (interventional radiologist), and Gabriel Schnickel (transplant and hepatobiliary surgeon).

VI

VI Episode #523

Are you seeking to build your reputation and patient base within interventional oncology? In this episode, host Dr. Zachary Berman interviews Dr. Siddarth Padia, Dr. Tyler Sandow, Dr. Kavi Krishnasamy, and Dr. Kevin Burns about their journeys into interventional oncology (IO) and their experiences providing care in different practice settings.

VI

VI Episode #522

Is there a way to treat liver metastasis secondary to uveal melanoma without introducing systemic, treatment-related toxicity? Dr. Altan Ahmed (interventional radiologist at Moffitt Cancer Center) and Dr. Sid Padia (interventional radiologist at UCLA) join guest-host Dr. Kavi Krishnasamy to discuss HEPZATO, a novel device-based treatment for liver metastases from uveal melanoma.

VI

VI Episode #521

Is surgery truly the "cure" for hepatocellular carcinoma (HCC), and when is it a viable option? In this episode, Dr. Sabeen Dhand leads a roundtable discussion with interventional radiologist Dr. Siddharth Padia and transplant/hepatobiliary surgeons Dr. John Seal and Dr. Gabriel Schnickel, delving into the complexities of surgical treatments for HCC and the evolving landscape of liver resection and transplantation.

VI

VI Episode #511

Of all the topics covered during interventional radiology training, dosimetry education is often delayed until after IRs enter clinical practice. In this episode, Drs. Tyler Sandow and Sabeen Dhand host a roundtable discussion with experts on the dosimetry fundamentals that all Y90 operators should understand. They are joined by interventional radiologists Drs. Zachary Berman, Kirema Garcia-Reyes, and Siddharth Padia, who provide their expert insights.

Tumor Board

Tumor Board Episode #9

Do you ever wish you could be a fly on the wall at a tumor board meeting? In this episode of BackTable, we’re excited to give you an insider’s view of the real case discussions that take place during hepatocellular carcinoma (HCC) tumor boards. Host Dr. Zach Berman sits down with a multidisciplinary team, including Drs. Adam Burgoyne (medical oncologist), Heather Patton (hepatologist), Siddharth Padia (interventional radiologist), and Gabriel Schnickel (transplant and hepatobiliary surgeon).

Tumor Board

Tumor Board Episode #8

Are you seeking to build your reputation and patient base within interventional oncology? In this episode, host Dr. Zachary Berman interviews Dr. Siddarth Padia, Dr. Tyler Sandow, Dr. Kavi Krishnasamy, and Dr. Kevin Burns about their journeys into interventional oncology (IO) and their experiences providing care in different practice settings.

Tumor Board

Tumor Board Episode #7

Is surgery truly the "cure" for hepatocellular carcinoma (HCC), and when is it a viable option? In this episode, Dr. Sabeen Dhand leads a roundtable discussion with interventional radiologist Dr. Siddharth Padia and transplant/hepatobiliary surgeons Dr. John Seal and Dr. Gabriel Schnickel, delving into the complexities of surgical treatments for HCC and the evolving landscape of liver resection and transplantation.

Tumor Board

Tumor Board Episode #2

Of all the topics covered during interventional radiology training, dosimetry education is often delayed until after IRs enter clinical practice. In this episode, Drs. Tyler Sandow and Sabeen Dhand host a roundtable discussion with experts on the dosimetry fundamentals that all Y90 operators should understand. They are joined by interventional radiologists Drs. Zachary Berman, Kirema Garcia-Reyes, and Siddharth Padia, who provide their expert insights.

Articles Featuring Dr. Siddharth Padia

MSK

As GAE gains traction for knee pain relief, interventionalists face key questions on integrating and determining best practices. Drs. Ahmed and Padia explore these topics, from follow-up strategies to repeat procedures, and consider the broader future of this evolving treatment.

MSK

Genicular artery embolization (GAE) is a minimally invasive procedure that reduces inflammation and pain in the knee for osteoarthritis patients. As it continues to evolve, Drs. Padia and Ahmed address important questions that remain regarding patient selection and technical approaches.

VI

The FDA-approved HEPZATO Kit offers a new liver-directed therapy for metastatic uveal melanoma. Drs. Ahmed and Padia discuss its clinical workflow, patient selection, and the evolving role of percutaneous hepatic perfusion in interventional radiology.

VI

HEPZATO is a therapeutic agent delivered via percutaneous hepatic perfusion (PHP) directly to the liver while minimizing systemic chemo-exposure. Drs. Ahmed and Padia cover how to optimize HEPZATO, including patient selection, drug dosing, and treatment cycles.

Tumor Board

What is the optimal treatment course for hepatocellular carcinoma patients that are potential candidates for liver transplant? This article reviews bridging and downstaging techniques, surgical planning after locoregional therapy, and the emerging risks of immunotherapy in transplant patients.

Tumor Board

Treatment of hepatocellular carcinoma often involves multidisciplinary evaluation to determine candidacy for surgical resection or transplant. This article outlines surgical indications and techniques used to treat or bridge patients to transplant.

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-plus-vi-cta.jpg

Podcasts

Genicular Artery Embolization: Current Controversies & Insights with Dr. Sid Padia and Dr. Osman Ahmed on the BackTable MSK Podcast
Genicular Artery Embolization: Current Controversies & Insights with Dr. Sid Padia and Dr. Osman Ahmed on the BackTable VI Podcast
Principles to Practice: An HCC Tumor Board with Dr. Gabe Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton and Dr. Sid Padia on the BackTable VI Podcast
Getting Started in Interventional Oncology: Tips for Starting Your Career with Dr. Sid Padia, Dr. Kevin Burns, Dr. Tyler Sandow and Dr. Venkatesh Krishnasamy on the BackTable VI Podcast
Advancements in Treatment of Metastatic Ocular Melanoma with Dr. Altan Ahmed and Dr. Sid Padia on the BackTable VI Podcast
Complex HCC Patients & The "Grey Zone": What To Do When You Don’t Know What To Do with Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Kirema Garcia-Reyes and Dr. Lingling Du on the BackTable Tumor Board Podcast

Topics

Biopsy Podcasts
Dosimetry Podcasts
Hepatobiliary Surgery Podcasts
Hepatology Podcasts
Immunotherapy Podcasts
Liver Cancer Podcasts

More Contributors

Dr. Osman Ahmed on the BackTable VI Podcast

Dr. Osman Ahmed

Dr. Sandeep Bagla on the BackTable VI Podcast

Dr. Sandeep Bagla

Dr. Aparna Baheti on the BackTable VI Podcast

Dr. Aparna Baheti

Dr. Michael Barraza on the BackTable VI Podcast

Dr. Michael Barraza

Dr. Ahmed Farag on the BackTable MSK Podcast

Dr. Ahmed Farag

Dr. Jacob Fleming on the BackTable MSK Podcast

Dr. Jacob Fleming

bottom of page